定义预测突发心脏死亡的临床相关风险阈值
Defining clinically relevant risk threshold for predicting sudden cardiac death
该研究通过荟萃分析和模拟,确定了植入式心脏复律除颤器(ICD)预防突发心脏死亡(SCD)的最低临床相关风险阈值。在考虑非突发死亡竞争风险的情况下,研究发现,平均年突发心脏死亡风险为3%(约5年内为12%)是实施ICD治疗的最低阈值。在非突发死亡风险极低的人群中,这一阈值在10年内可降低至1.3%。
- Article
- Open access
- Published: 31 October 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
There is no consensus on a risk threshold for sudden cardiac death (SCD) that could be used in practical design and evaluation of prediction models and decisions regarding implantable cardioverter-defibrillator (ICD) therapy. Baseline assumptions for a simulation framework were derived from previous randomized controlled trials (n = 18) to identify minimal average SCD risk threshold that would translate to mortality benefit by ICD therapy also considering the effect of competing non-sudden mortality. ICD efficacy to prevent SCDs and other data for simulations were estimated using inverse-variance weighted meta-analysis of included trials. Number needed to treat (NNT) was evaluated over a 5- and 10-year horizons (≤ 20 defined as clinically relevant). Correlation analysis confirmed average annual SCD incidence in trial populations as the key factor associating with ICD therapy effectiveness to reduce mortality (Pearson’s r = 0.653, p < 0.01). In a simulation assuming 5% annual non-sudden mortality (pooled estimate of included RCTs) and a 56% (48–62%) efficacy for ICDs to reduce SCDs or similar events, 3% average annual SCD risk (≈ 12% over 5 years) emerged as the lowest practical threshold even after controlling for excess (overlapping) mortality among those saved successfully from SCD by ICD therapy. In populations with very low incidence of non-sudden mortality (1%), the lowest practical threshold over a longer 10-year time horizon was 1.3% (assuming no overlapping mortality). Even under substantial competing risk, populations with an average 3% (or higher) annual SCD incidence most likely would benefit from ICD therapy. Lower threshold may be considered only in populations with very low non-sudden mortality.
Acknowledgements
This study was supported by Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, Tampere University Hospital support association, Finnish Foundation for Cardiovascular Research, Aarne Koskelo Foundation, Paavo ja Eila Salonen Foundation and European Union (CVDLink, EU Grant 101137278). The funders had no role in the study design; data collection, analysis, or interpretation; writing of the report; or the decision to submit the paper for publication.
Author information
Authors and Affiliations
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
Jussi Hernesniemi, Roni Ahola & Mikko Uimonen
Heart Hospital, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland
Jussi Hernesniemi & Mikko Uimonen
Authors
- Jussi Hernesniemi
- Roni Ahola
- Mikko Uimonen
Corresponding author
Correspondence to Jussi Hernesniemi.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hernesniemi, J., Ahola, R. & Uimonen, M. Defining clinically relevant risk threshold for predicting sudden cardiac death. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78332-5
Received: 29 May 2026
Accepted: 26 October 2026
Published: 31 October 2026
DOI: https://doi.org/10.1038/s41598-026-78332-5
Keywords
来源:Nature 健康护理主题 · nature.com